Anti-CD47 antibodies promote phagocytosis and inhibit the growth of human myeloma cells (Q84251637)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22648449%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

title

Anti-CD47 antibodies promote phagocytosis and inhibit the growth of human myeloma cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22648449%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

D Kim

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22648449%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

J Wang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22648449%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

S B Willingham

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22648449%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

R Martin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22648449%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

G Wernig

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22648449%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

I L Weissman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22648449%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

publication date

30 May 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22648449%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22648449%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22648449%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22648449%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

2538-2545

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22648449%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2012.141

2 February 2020

exact match

0 references

cites work

A unique three-dimensional model for evaluating the impact of therapy on multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.141

7 January 2021

https://api.crossref.org/works/10.1038%2FLEU.2012.141

1 reference

7 January 2021

Isolation and characterization of CD47 glycoprotein: a multispanning membrane protein which is the same as integrin-associated protein (IAP) and the ovarian tumour marker OA3

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.141

7 January 2021

Role of CD47 as a marker of self on red blood cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.141

7 January 2021

CD47-signal regulatory protein alpha (SIRPalpha) regulates Fcgamma and complement receptor-mediated phagocytosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.141

7 January 2021

Involvement of a CD47-dependent pathway in platelet adhesion on inflamed vascular endothelium under flow

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.141

7 January 2021

A novel member of the integrin receptor family mediates Arg-Gly-Asp-stimulated neutrophil phagocytosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.141

7 January 2021

Integrin-associated protein: a 50-kD plasma membrane antigen physically and functionally associated with integrins

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.141

7 January 2021

CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.141

7 January 2021

CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.141

7 January 2021

Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.141

7 January 2021

Extranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.141

7 January 2021

Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.141

7 January 2021

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.141

7 January 2021

Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.141

7 January 2021

The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.141

7 January 2021

Immunophenotypic differentiation between neoplastic plasma cells in mature B-cell lymphoma vs plasma cell myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.141

7 January 2021

The proteasome: a suitable antineoplastic target

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.141

7 January 2021

CD19-CD45 low/- CD38 high/CD138+ plasma cells enrich for human tumorigenic myeloma cells.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.141

7 January 2021

Therapeutic antibody targeting of CD47 eliminates human acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.141

7 January 2021

Apoptosis inducing bivalent single-chain antibody fragments against CD47 showed antitumor potency for multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.141

7 January 2021

Distinct mouse bone marrow macrophage precursors identified by differential expression of ER-MP12 and ER-MP20 antigens

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.141

7 January 2021

Negative regulation of platelet clearance and of the macrophage phagocytic response by the transmembrane glycoprotein SHPS-1.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.141

7 January 2021

Negative regulation of phagocytosis in macrophages by the CD47-SHPS-1 system

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.141

7 January 2021

Role for CD47-SIRPalpha signaling in xenograft rejection by macrophages

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.141

7 January 2021

A bivalent single-chain Fv fragment against CD47 induces apoptosis for leukemic cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.141

7 January 2021

CD47 ligation induces a rapid caspase-independent apoptosis-like cell death in human monocytes and dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.141

7 January 2021

CD47 (integrin-associated protein) engagement of dendritic cell and macrophage counterreceptors is required to prevent the clearance of donor lymphohematopoietic cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.141

7 January 2021

Chemokine stromal cell-derived factor-1alpha modulates VLA-4 integrin-mediated multiple myeloma cell adhesion to CS-1/fibronectin and VCAM-1.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.141

7 January 2021

A crosstalk between myeloma cells and marrow stromal cells stimulates production of DKK1 and interleukin-6: a potential role in the development of lytic bone disease and tumor progression in multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.141

7 January 2021

Consequences of interactions between the bone marrow stroma and myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.141

7 January 2021

In vitro culture of primary plasmacytomas requires stromal cell feeder layers

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.141

7 January 2021

Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.141

7 January 2021

Dominant role of CD47-thrombospondin-1 interactions in myeloma-induced fusion of human dendritic cells: implications for bone disease

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.141

7 January 2021